Division of Allergy Pulmonary and Critical Care Medicine

Vanderbilt University Medical Center is working with scientists around the U.S. to launch the first Phase III, multicenter, placebo-controlled trial to determine the effect of immunomodulation on Long COVID.

John H. Newman, MD, an acclaimed physician-scientist in Vanderbilt University Medical Center’s Division of Allergy, Pulmonary and Critical Care Medicine who made numerous contributions to the knowledge of pulmonary vascular disease, died on Tuesday, Feb. 20, after a several-month illness. He was 78.

Timothy Blackwell, MD, director of the Division of Allergy, Pulmonary and Critical Care Medicine, is leaving Vanderbilt University Medical Center to chair the Department of Internal Medicine at the University of Michigan.

Four Vanderbilt physician-scientists have received awards from the American Society for Clinical Investigation.

Vanderbilt's Stokes Peebles, MD, has been appointed to the National Advisory Allergy and Infectious Diseases Council.

Three physician scientists from Vanderbilt University Medical Center have been elected this year to membership in the American Society for Clinical Investigation, one of the nation’s oldest and most respected medical honor societies.

A Vanderbilt study found that two antibiotics thought to cause kidney failure in ICU patients with a severe bacterial infection, especially when combined with another antibiotic, may be safer for the kidneys than previously reported.